• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.57% Nasdaq Up 2.12%

    Retrophin, Inc. (RTRX)

    -NasdaqGM
    17.81 Up 0.57(3.31%) 4:00PM EDT
    |After Hours : 17.81 0.00 (0.00%) 4:39PM EDT
    Prev Close:17.24
    Open:17.41
    Bid:16.76 x 100
    Ask:19.30 x 300
    1y Target Est:24.67
    Beta:1.12973
    Earnings Date:Aug 2 - Aug 8 (Est.)
    Day's Range:17.40 - 18.02
    52wk Range:11.60 - 37.04
    Volume:419,044
    Avg Vol (3m):489,360
    Market Cap:653.21M
    P/E (ttm):9.27
    EPS (ttm):1.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.23
    Quarterly EPS Est (Jun-16) :-0.28
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-1.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback